Learnings from Contour Neurovascular System™ clinical experience

During LINNC Paris 2023 at the Stryker symposium, Prof Monika KILLER-OBERPFALZER presented her clinical experience and latest data concerning the Contour™ intrasaccular device. We join her and Dr. Patrick NICHOLSON as they discuss this new entry into the field of aneurysm treatment and see how it compares to other techniques.

The Contour™ has a unique architecture which, in Prof KILLER’s extensive experience, makes it easy to use as well as safe and effective. Designed to cover the neck of the aneurysm, unlike the WEB device which requires the operator pay attention to the aneurysm shape – the Contour™ occludes the aneurysm “similar to the way we would occlude an aneurysm with a stent”. But, unlike stents, dual antiplatelet therapy is not necessary past the first day with the Contour™. In this discussion, you will discover the different techniques used by the operator to deploy the Contour™. Discover how your experience would differ with that of deploying a WEB device or how Prof. KILLER positions the device correctly, with a discussion on how the correct positioning should appear in the 3D imaging of the parent artery. Dr NICHOLSON asks whether it is necessary to jail, or use coils with the Contour™? The discussion then turns to what size aneurysm would require stabilizing the Contour™ and why, with all of these questions answered in the ensuing exchange. Dr. NICHOLSON goes on to enquire about follow-up and the frequency of follow-up ending by asking Prof. KILLER to speak about the future of the Contour™ in the treatment of aneurysms: Which patients can most benefit? What do further iterations hold in store?

Join us now and learn more about the novel Contour™ intrasaccular device and Contour Neurovascular System™.

Sponsored by Stryker